Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Lumentum Holdings Inc. saw its shares climb after Nasdaq confirmed the company will enter the Nasdaq-100 Index, replacing CoStar Group prior to the market open on Monday, May 18, 2026. The move obliges funds that track the index to add Lumentum to their portfolios, a development that typically increases demand for included stocks.
IREN Limited intends to raise $2 billion through a private offering of convertible senior notes due 2033, with an option to issue an additional $300 million. The notes will accrue interest, be convertible under certain conditions, and redeemable subject to conditions. Proceeds will fund capped call transactions to mitigate dilution and general corp…
Apogee Therapeutics announced strong 52-week Phase 2 data for its lead drug candidate zumilokibart in treating atopic dermatitis, demonstrating durable and improved efficacy with extended dosing intervals. The company plans to initiate Phase 3 trials later in 2026 and expand clinical development into asthma and eosinophilic esophagitis indications.…
RoboStrategy, Inc., a closed-end investment fund focusing on robotics and physical AI companies, has begun trading on the NASDAQ under the ticker BOT. The fund offers public investors exposure to a concentrated portfolio of private, pre-IPO, and public robotics firms, bridging the gap between venture capital opportunities and public markets. This d…
Gray Media, Inc. announced the promotion of James Finch to Senior Vice President of News Services in recognition of his 30 years of contributions and increasing responsibilities managing news operations for the company's local TV stations and digital platforms. The company is the largest owner of local television stations in the US, encompassing 12…
Sagimet Biosciences announced preclinical data demonstrating the potential of fatty acid synthase (FASN) inhibitors to reduce sebum production, a key factor in acne. This supports their upcoming Phase 3 clinical trial of denifanstat for moderate to severe acne in the U.S., planned to initiate in the second half of 2026. The data will be presented a…
Actuate Therapeutics announced FDA clearance for an IND to begin Phase 1/2 clinical trials of their oral elraglusib formulation in advanced cancers including metastatic melanoma, NSCLC, colorectal, and pancreatic cancers, aiming to improve patient convenience and drug exposure. The company also revealed plans to study elraglusib in combination with…
Hain Celestial announced its fiscal third quarter 2026 financial results, reporting a 13% year-over-year decline in net sales to $338 million, with organic net sales down 6%. Despite lower revenues and a net loss of $106 million driven partly by asset impairments and the sale of its North American snacks business, the company improved its financial…
Fractyl Health received authorization to start a Phase 1/2 clinical trial of RJVA-001, its first gene therapy candidate aimed at treating type 2 diabetes by enabling nutrient-responsive GLP-1 expression in the pancreas. This marks the company's advancement to a dual clinical-stage biotech, with RJVA-001 being the first adeno-associated virus-based …
SailPoint, a leader in enterprise identity security, announced the launch of SailPoint Agentic Fabric, a solution designed to govern and secure AI agents and non-human identities at scale. This new platform extends identity security beyond human users to AI agents, machines, and applications, providing unified discovery, governance, and protection …
Multi Ways Holdings Limited, a NYSE American-listed heavy construction equipment supplier in Singapore and the surrounding region, announced a 44.2% revenue increase to $44.8 million for fiscal year 2025. The company's equipment sales grew 54%, driven by robust infrastructure projects and public-private construction activities in Singapore. Improve…
Village Farms International, Inc. reported a robust first quarter for 2026, highlighting a 27% increase in consolidated net sales to $50.2 million and a 118% surge in adjusted EBITDA from continuing operations to $9.9 million. Key growth drivers include a 171% increase in international medical cannabis exports and continued market share gains in Ca…
Alpha Tau Medical Ltd. announced groundbreaking interim results from their U.S. trial of Alpha DaRT therapy in patients with recurrent glioblastoma. Among the first three patients treated, two showed complete responses with total tumor disappearance, while the third had stable disease and tumor reduction. The treatment was generally well tolerated …
Gain Therapeutics announced its Q1 2026 financial results along with significant progress in clinical development of its lead Parkinson's disease drug candidate GT-02287. The company highlighted promising Phase 1b study data indicating potential disease-modifying effects, ongoing FDA engagement, and plans to initiate Phase 2 clinical trials in Q3 2…
Lexeo Therapeutics reported Q1 2026 financial results and operational highlights, including FDA submission of SUNRISE-FA 2 pivotal trial protocol for LX2006, presentation of new data at ASGCT 2026, and a strong cash position of $227.6 million to fund operations into 2028. The company made progress in clinical trials for genetic cardiovascular disea…
MBX Biosciences provided preliminary blinded Phase 1 data for MBX 4291, a GLP-1/GIP co-agonist prodrug for obesity, demonstrating mean weight loss of 7% at 8 weeks and a pharmacokinetic profile supportive of once-monthly dosing. The drug was generally well tolerated with minimal gastrointestinal side effects. The company also announced MBX 5765 as …
Erasca, Inc. announced a clinical collaboration and supply agreement with Merck to conduct the AURORAS-1 study evaluating their investigational pan-RAS molecular glue ERAS-0015 in combination with Merck's KEYTRUDA (pembrolizumab) for RAS-mutant solid tumors. The agreement includes Merck supplying pembrolizumab at no cost and aims to improve treatme…
Rezolute, Inc., a late-stage biotechnology company focused on rare diseases related to hyperinsulinism, announced its management will participate in two major upcoming investor conferences. The participation includes fireside chats and one-on-one meetings, aiming to update investors on their developments, including their antibody therapy ersodetug,…
Keel Infrastructure Corp., rebranded and redomiciled in the U.S., reported its Q1 2026 financial results highlighting a strategic shift from Bitcoin mining to high-performance computing (HPC) and AI data center infrastructure in North America. The company reported a net loss of $145 million primarily due to operational costs, impairments, and adjus…
ARKO Petroleum Corp. announced robust financial results for Q1 2026, including a net income increase to $8.1 million and adjusted EBITDA up to $36.4 million compared to the previous year. The company completed an IPO raising $206.7 million used to significantly reduce debt, enhancing financial flexibility. Growth strategies include converting retai…
Kaspi.kz announced robust financial results for Q1 2026 with a 41% year-over-year growth in e-Commerce gross merchandise value and a 9% increase in adjusted EBITDA. The company highlighted increased consumer purchase frequency and improved monetization, particularly in advertising and delivery services. Kaspi.kz is expanding internationally with si…
Goldman Sachs has trimmed its 12-month probability of a U.S. recession by 5 percentage points to 25%. The firm still sees growth running below trend and expects unemployment to rise. It now projects two 25 basis point Federal Reserve rate cuts in December 2026 and March 2027, delayed three months from its prior timing, citing both lower recession r…
The European Commission is engaged in separate conversations with US artificial intelligence developers OpenAI and Anthropic. OpenAI has proactively offered to grant the Commission access to its new AI model, while the Commission has held multiple meetings with Anthropic but has not yet reached discussions about model access, a spokesperson said.
Demining teams around Myrotske and Ivankiv in central Ukraine are deploying a mix of traditional manual detection, remote-operated excavation and artificial intelligence trained on high-resolution drone imagery to locate and remove unexploded ordnance left after occupation. Organisations say the scale of contamination is vast and progress is being …
Blackstone has agreed to acquire Greek e-commerce platform Skroutz from CVC Capital Partners Fund VII in a transaction that values the company, including debt, at about 635 million euros. CVC is set to double its initial investment, and the platform's founders will sell part of their stake while keeping a share and continuing to lead operations und…
